Nanosonics Limited (NNCSF)
USD 3.4
(17.65%)
USD 3.4
(17.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 59.67 Million AUD | -11.38% |
| 2023 | 62.21 Million AUD | 14.05% |
| 2022 | 54.55 Million AUD | 88.06% |
| 2021 | 29 Million AUD | 20.88% |
| 2020 | 23.99 Million AUD | 17.97% |
| 2019 | 20.34 Million AUD | 27.87% |
| 2018 | 15.9 Million AUD | 30.05% |
| 2017 | 12.23 Million AUD | 6.31% |
| 2016 | 11.5 Million AUD | -26.67% |
| 2015 | 15.68 Million AUD | 19.68% |
| 2014 | 13.1 Million AUD | 9.74% |
| 2013 | 11.94 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 51.57 Million AUD | 0.0% |
| 2024 FY | 59.67 Million AUD | -4.08% |
| 2024 Q4 | 59.67 Million AUD | 0.0% |
| 2024 Q3 | 55.13 Million AUD | 6.9% |
| 2024 Q1 | 51.57 Million AUD | -17.1% |
| 2023 Q2 | 50.06 Million AUD | 0.0% |
| 2023 FY | 62.21 Million AUD | 14.05% |
| 2023 Q4 | 62.21 Million AUD | 10.98% |
| 2023 Q1 | 50.06 Million AUD | -9.07% |
| 2023 Q3 | 56.06 Million AUD | 11.97% |
| 2022 FY | 54.55 Million AUD | 88.06% |
| 2022 Q3 | 48.46 Million AUD | 55.88% |
| 2022 Q4 | 55.06 Million AUD | 13.61% |
| 2022 Q2 | 31.09 Million AUD | 0.0% |
| 2022 Q1 | 31.09 Million AUD | 7.19% |
| 2021 Q4 | 29 Million AUD | 8.49% |
| 2021 Q2 | 19.93 Million AUD | 0.0% |
| 2021 Q1 | 19.93 Million AUD | -16.91% |
| 2021 FY | 29 Million AUD | 20.88% |
| 2021 Q3 | 26.73 Million AUD | 34.09% |
| 2020 Q1 | 18.68 Million AUD | -3.88% |
| 2020 Q3 | 22.84 Million AUD | 22.25% |
| 2020 Q4 | 23.99 Million AUD | 5.06% |
| 2020 FY | 23.99 Million AUD | 17.97% |
| 2020 Q2 | 18.68 Million AUD | 0.0% |
| 2019 Q3 | 19.43 Million AUD | 28.13% |
| 2019 Q4 | 19.43 Million AUD | 0.0% |
| 2019 FY | 20.34 Million AUD | 27.87% |
| 2019 Q1 | 15.17 Million AUD | 1.97% |
| 2019 Q2 | 15.17 Million AUD | 0.0% |
| 2018 Q2 | 11.68 Million AUD | 0.0% |
| 2018 Q4 | 14.87 Million AUD | 0.0% |
| 2018 FY | 15.9 Million AUD | 30.05% |
| 2018 Q3 | 14.87 Million AUD | 27.3% |
| 2018 Q1 | 11.68 Million AUD | -2.65% |
| 2017 Q4 | 12 Million AUD | 0.0% |
| 2017 Q2 | 10.68 Million AUD | 0.0% |
| 2017 Q1 | 10.68 Million AUD | -7.11% |
| 2017 FY | 12.23 Million AUD | 6.31% |
| 2017 Q3 | 12 Million AUD | 12.33% |
| 2016 FY | 11.5 Million AUD | -26.67% |
| 2016 Q3 | 11.5 Million AUD | -35.81% |
| 2016 Q2 | 17.92 Million AUD | 0.0% |
| 2016 Q4 | 11.5 Million AUD | 0.0% |
| 2016 Q1 | 17.92 Million AUD | 14.23% |
| 2015 Q3 | 15.68 Million AUD | 7.58% |
| 2015 Q1 | 14.58 Million AUD | 11.24% |
| 2015 Q4 | 15.68 Million AUD | 0.0% |
| 2015 FY | 15.68 Million AUD | 19.68% |
| 2015 Q2 | 14.58 Million AUD | 0.0% |
| 2014 Q2 | 12.52 Million AUD | 0.0% |
| 2014 Q4 | 13.1 Million AUD | 0.0% |
| 2014 FY | 13.1 Million AUD | 9.74% |
| 2014 Q1 | 12.52 Million AUD | 4.8% |
| 2014 Q3 | 13.1 Million AUD | 4.7% |
| 2013 Q3 | 11.94 Million AUD | 2.88% |
| 2013 FY | 11.94 Million AUD | 0.0% |
| 2013 Q2 | 11.61 Million AUD | 0.0% |
| 2013 Q4 | 11.94 Million AUD | 0.0% |
| 2013 Q1 | 11.61 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -2439.488% |
| Ansell Limited | 1.32 Billion USD | 95.513% |
| Ansell Limited | 1.33 Billion USD | 95.521% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 52.766% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -6226.948% |
| Psykey, Inc. | 2.47 Million USD | -2312.027% |
| ConvaTec Group Plc | 2.01 Billion USD | 97.043% |
| ConvaTec Group Plc | 2.02 Billion USD | 97.047% |
| Encision Inc. | 1.98 Million USD | -2907.811% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -1862.651% |
| Innovative MedTech Inc. | 6.13 Million USD | -872.706% |
| LifePoint, Inc. | 2.45 Million USD | -2331.536% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -486.131% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -1655.118% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -1862.752% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -7586.69% |
| SmileDirectClub, Inc. | 982.26 Million USD | 93.925% |
| Sector 10, Inc. | 9.84 Million USD | -506.109% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 95.598% |
| SheerVision, Inc. | 1.43 Million USD | -4068.917% |
| United Health Products, Inc. | 1.99 Million USD | -2885.388% |
| Vasamed, Inc. | 1 Million USD | -5835.94% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -1470.251% |
| Yubo International Biotech Limited | 2.91 Million USD | -1947.891% |